United Therapeutics Corporation · NASDAQ:UTHR

Rothblatt Martine A sold 9,500 United Therapeutics Corporation shares (Form 4)

Traded Oct 15, 2026 · Filed Oct 16, 2026

On Oct 15, 2026, Rothblatt Martine A (Director, Chairperson & CEO) sold 9,500 United Therapeutics Corporation shares at an average US$546.65 for US$5.19M under a trading plan, leaving 324,443 shares. Filed Oct 16, 2026 (Form 4).

Sold
9,500 shares
Price
US$546.65 average (US$540.48 to US$551.50)
Value
US$5.19M
Holding after
324,443 shares (held indirectly)
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Chairperson & CEO

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Oct 15, 2026Common StockOption exercise9,500US$117.76333,943Indirect
Oct 15, 2026Common StockSale281US$540.48333,662Indirect
Oct 15, 2026Common StockSale1,163US$541.59332,499Indirect
Oct 15, 2026Common StockSale456US$542.68332,043Indirect
Oct 15, 2026Common StockSale371US$543.39331,672Indirect
Oct 15, 2026Common StockSale269US$544.75331,403Indirect
Oct 15, 2026Common StockSale825US$545.87330,578Indirect
Oct 15, 2026Common StockSale601US$546.94329,977Indirect
Oct 15, 2026Common StockSale2,166US$547.83327,811Indirect
Oct 15, 2026Common StockSale2,039US$548.89325,772Indirect
Oct 15, 2026Common StockSale1,009US$549.76324,763Indirect
Oct 15, 2026Common StockSale200US$550.72324,563Indirect
Oct 15, 2026Common StockSale120US$551.50324,443Indirect

Source

Download original · View original at SEC

Related